NEW ORLEANS, Sept. 08, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 23, 2017 to file lead plaintiff applications in a securities class action lawsuit against Top Ships Inc. (Nasdaq:TOPS), if they purchased the Company’s shares between January 17, 2017 and August 22, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Top Ships investors should visit us at https://www.claimsfiler.com/cases/view-top-ships-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Top Ships and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
Throughout 2017, Top Ships engaged in a stock scheme of selling tens of millions of its shares to Kalani Investments Limited at a deeply discounted rate and then filing registration statements enabling Kalani to resell the shares. As the selloff caused the share price to decline, Top Ships would then artificially raise the price via a reverse stock split, causing shares to be merged.
As a result of this scheme, the price of Top Ships’ shares has plummeted by more than 99%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FDA Approves Mitapivat for Anemia in Thalassemia Patients
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 



